 |
 |
 |
Development of Normal Prostate
Authors
C Butler,
A Swain
Institute of Cancer Research
Source of funding: NCRI
Developmental Genetics of the Prostate
Given that carcinogenesis often involves deregulation of developmental
regulatory genes, a molecular analysis of normal development of
the prostate should provide important insight into prostate cancer.
Although the androgen-dependent nature of prostate development has
been well established, it is not clear how androgens regulate prostate
differentiation and growth. Identification of the gene pathways
regulated by androgens during prostate development is essential
for the understanding of normal and disease processes of this male-specific
organ. The use of high-density cDNA hybridisation arrays and subtractive
hybridisation techniques can identify these gene pathways. These
can be further studied by transgenic analysis in mouse models.
In a collaboration with Dr. Bento Soares (University of Iowa) we
have developed a normalised cDNA library derived from neonatal mouse
prostate. We are screening this library to identify overexpressed
clones in the developing male prostate compared to female tissues.
Genes of interest will be sequenced and their expression characterised
by whole-mount in situ hybridisation and subjected to functional
analysis using in vitro organ cultures, transgenic and/or targeted
mutagenesis in the mouse. Genes identified in this project may provide
useful prognostic markers for early prostate cancer.
|
|
|
|
|
Developing epithelial buds of the prostate - marked by
the gene Nkx3.1 |
Expression of E-cadherin in the developing seminal vesicles |
|
|
 |
Collaborative
Home Page
Quick Links to other pages
grey = under construction
Aetiology and Genetics
Epidemiological Identification of Families
Genetic Susceptibility
Diet and Environment
Chemoprevention
Molecular Pathology
Links to Cancer Genome Project
Development of Normal Prostate
Microarray Expression Profiling
Candidate Genes
Novel Telomerase Suppressor Genes
Subtractive Hybridization
CESH
Novel Therapies
New Drugs for Prostate Cancer
Intensity Modulated Radiotherapy
Immunotherapy
Novel Targets from Cancer Genome Project
Novel Mechanism Based Drugs
Core Resources
Cancer Gene Cloning Lab
Prostate Tissue arrays
Microarray laboratory
Tissue and blood collections
Bioinformatics
Pilot and Development Funds
Tumor micro-environment in early prostate cancer
Collaborations
Meetings and Seminars
|
 |